Details for Patent: 10,493,028
✉ Email this page to a colleague
Which drugs does patent 10,493,028 protect, and when does it expire?
Patent 10,493,028 protects FIRVANQ KIT and is included in one NDA.
This patent has nine patent family members in seven countries.
Drugs Protected by US Patent 10,493,028
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | FIRVANQ KIT | vancomycin hydrochloride | FOR SOLUTION;ORAL | 208910-001 | Jan 26, 2018 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Azurity | FIRVANQ KIT | vancomycin hydrochloride | FOR SOLUTION;ORAL | 208910-002 | Jan 26, 2018 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,493,028
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015229069 | ⤷ Sign Up | |||
| Canada | 2941867 | ⤷ Sign Up | |||
| China | 106573037 | ⤷ Sign Up | |||
| European Patent Office | 3145527 | ⤷ Sign Up | |||
| European Patent Office | 4000628 | ⤷ Sign Up | |||
| Spain | 2903419 | ⤷ Sign Up | |||
| Japan | 2017508807 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
